Works matching IS 00099236 AND DT 2016 AND VI 100 AND IP 3

Results: 20

In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 268, doi. 10.1002/cpt.372
By:
- Cuzzoni, E;
- De Iudicibus, S;
- Stocco, G;
- Favretto, D;
- Pelin, M;
- Messina, G;
- Ghio, L;
- Monti, E;
- Pasini, A;
- Montini, G;
- Decorti, G
Publication type:
Article
Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 223, doi. 10.1002/cpt.373
By:
- Burmeister Getz, E;
- Carroll, KJ;
- Jones, B;
- Benet, LZ
Publication type:
Article
The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 275, doi. 10.1002/cpt.390
By:
- Coplan, PM;
- Chilcoat, HD;
- Butler, SF;
- Sellers, EM;
- Kadakia, A;
- Harikrishnan, V;
- Haddox, JD;
- Dart, RC
Publication type:
Article
CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 252, doi. 10.1002/cpt.392
By:
- Turtle, CJ;
- Riddell, SR;
- Maloney, DG
Publication type:
Article
Mechanistic Projection of First-in-Human Dose for Bispecific Immunomodulatory P-Cadherin LP-DART: An Integrated PK/PD Modeling Approach.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 232, doi. 10.1002/cpt.393
By:
- Chen, X;
- Haddish‐Berhane, N;
- Moore, P;
- Clark, T;
- Yang, Y;
- Li, H;
- Xuan, D;
- Barton, HA;
- Betts, AM;
- Barletta, F
Publication type:
Article
Immune-Related Adverse Events From Immune Checkpoint Inhibitors.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 242, doi. 10.1002/cpt.394
By:
- Marrone, KA;
- Ying, W;
- Naidoo, J
Publication type:
Article
ASCPT News.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 206, doi. 10.1002/cpt.410
Publication type:
Article
In This Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 197, doi. 10.1002/cpt.413
Publication type:
Article
Highlights.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 204, doi. 10.1002/cpt.414
Publication type:
Article
Implications of Programmed Cell Death 1 Ligand 1 Heterogeneity in the Selection of Patients With Non-Small Cell Lung Cancer to Receive Immunotherapy.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 220, doi. 10.1002/cpt.360
By:
- Mansfield, AS;
- Dong, H
Publication type:
Article
Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 215, doi. 10.1002/cpt.365
By:
- Stroh, M;
- Lum, BL
Publication type:
Article
Teratogenic drugs and their drug interactions with hormonal contraceptives.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 217, doi. 10.1002/cpt.384
By:
- Ahn, MR;
- Li, L;
- Shon, J;
- Bashaw, ED;
- Kim, M‐J
Publication type:
Article
The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapy.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 212, doi. 10.1002/cpt.385
By:
- Villaruz, LC;
- Socinski, MA
Publication type:
Article
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 287, doi. 10.1002/cpt.401
By:
- Scott, SA;
- Collet, J‐P;
- Baber, U;
- Yang, Y;
- Peter, I;
- Linderman, M;
- Sload, J;
- Qiao, W;
- Kini, AS;
- Sharma, SK;
- Desnick, RJ;
- Fuster, V;
- Hajjar, RJ;
- Montalescot, G;
- Hulot, J‐S
Publication type:
Article
Immunotherapy to Treat Cancer.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 198, doi. 10.1002/cpt.404
By:
- McCune, JS
Publication type:
Article
Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 259, doi. 10.1002/cpt.406
By:
- Stopfer, P;
- Giessmann, T;
- Hohl, K;
- Sharma, A;
- Ishiguro, N;
- Taub, ME;
- Zimdahl‐Gelling, H;
- Gansser, D;
- Wein, M;
- Ebner, T;
- Müller, F
Publication type:
Article
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 295, doi. 10.1002/cpt.407
By:
- Marsousi, N;
- Samer, CF;
- Fontana, P;
- Reny, JL;
- Rudaz, S;
- Desmeules, JA;
- Daali, Y
Publication type:
Article
Issue Information - Ed Board.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 191, doi. 10.1002/cpt.237
Publication type:
Article
Issue Information - TOC.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 193, doi. 10.1002/cpt.238
Publication type:
Article
Issue Information - Subscription Page.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 192, doi. 10.1002/cpt.239
Publication type:
Article